From: Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients
PHARYNX | ILD | PLD | LVD | Lymphatic Invasion | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Frequency | 90% (45/50) | 90% (45/50) | 96% (48/50) | 58% (29/50) | |||||||||
Mean (S.E.) | 19.14 (1.97) | 27.41 (2.57) | 26.47 (1.92) | ||||||||||
Score range | 0-78.39 | 0-82.17 | 8.5 -79.34 | ||||||||||
N | Mean (S.E) | p¥ | N | Mean (S.E) | p¥ | N | Mean range | p# | Absent | Present | Total | p* | |
Anatomic site | |||||||||||||
Hypopharynx | 18 | 19.92 (3.48) | 0.8600 | 18 | 30.87 (3.91) | 0.3470 | 18 | 29.67 | 0.0810 | 12 | 6 | 18 | 0.0230 |
Oropharynx | 31 | 19.18 (2.45) | 31 | 25.70 (3.46) | 31 | 22.29 | 9 | 22 | 31 | ||||
Total | 49 | 49 | 49 | 21 | 28 | 49 | |||||||
pT | |||||||||||||
T1-2 | 11 | 14.71 (3.53) | 0.236 | 11 | 27.45 (3.12) | 0.993 | 11 | 29.18 | 0.343 | 4 | 7 | 11 | 0.668 |
T3-4 | 39 | 20.39 (2.30) | 39 | 27.39 (3.11) | 39 | 24.46 | 17 | 22 | 39 | ||||
Total | 50 | 50 | 50 | 21 | 29 | 50 | |||||||
Nodal involvement | |||||||||||||
Free | 9 | 16.30 (3.90) | 0.3330 | 9 | 26.94 (7.77) | 0.3450 | 9 | 27.50 | 0.6550 | 5 | 4 | 9 | 0.3630 |
Affected | 41 | 19.77 (2.25) | 41 | 27.51 (2.69) | 41 | 25.06 | 16 | 25 | 41 | ||||
Total | 50 | 50 | 50 | 21 | 29 | 50 | |||||||
Tumour Stage | |||||||||||||
I-II | 4 | 12.12 (7.01) | 0.3720 | 4 | 19.05 (8.74) | 0.3650 | 4 | 28.13 | 0.4280 | 4 | 0 | 4 | 0.0100 |
III-IV | 41 | 19.60 (2.29) | 41 | 28.57 (2.99) | 41 | 22.50 | 14 | 27 | 41 | ||||
Total | 45 | 45 | 45 | 18 | 27 | 45 | |||||||
Recurrence | |||||||||||||
No | 23 | 19.19 (2.37) | 0.9140 | 23 | 26.41 (4.34) | 0.7410 | 23 | 24.39 | 0.8480 | 9 | 14 | 23 | 0.6420 |
Yes | 24 | 18.73 (3.45) | 24 | 28.24 (3.43) | 24 | 23.63 | 11 | 13 | 24 | ||||
Total | 47 | 47 | 47 | 20 | 27 | 47 |